Suchergebnisse - "Dauby, Nicolas"

PubPharm (173)

101

Multimodal Imaging in AIDS-Related Ocular Cryptococcosis

enthalten in: Case reports in ophthalmological medicine | 2021

von Flores Herrera, M. | Dauby, N. | Maillart, E. | +6

102

Adding barriers to barriers during the COVID-19 pandemic : a call for interdisciplinary research on communication with migrant patients in the emergency department

enthalten in: European journal of emergency medicine : official journal of the European Society for Emergency Medicine | 2021

von Cox, A. | Iedema, R. | Li, S. | +3

103

Model informed dosing of hydroxycholoroquine in COVID‐19 patients : Learnings from the recent experience, remaining uncertainties and gaps

enthalten in: British Journal of Clinical Pharmacology | 2021

von Thémans, P. | Dauby, N. | Schrooyen, L. | +12

104

Tolerability of favipiravir therapy in critically ill patients with COVID‐19 : A report of four cases

enthalten in: Journal of Medical Virology | 2021

von Dauby, N. | Van Praet, S. | Vanhomwegen, C. | +3

105

Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients : Implications for Dose Optimization

enthalten in: European journal of drug metabolism and pharmacokinetics | 2020

von Thémans, P. | Belkhir, L. | Dauby, N. | +14

106

Correction to : A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

enthalten in: Trials | 2020

von Devos, T. | Geukens, T. | Schauwvlieghe, A. | +22

ErratumFor: Trials. 2020 Nov 27;21(1):981. - PMID 33246499

107

Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

enthalten in: Trials | 2020

von Devos, T. | Geukens, T. | Schauwvlieghe, A. | +22

108

A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von Nagant, C. | Ponthieux, F. | Smet, J. | +6

109

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

enthalten in: Trials | 2020

von Devos, T. | Geukens, T. | Schauwvlieghe, A. | +22

ErratumIn: Trials. 2020 Dec 14;21(1):1024. - PMID 33317581

110

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

enthalten in: Trials | 2020

von Devos, T. | Geukens, T. | Schauwvlieghe, A. | +22